Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Mild GI symptoms are common with weight loss drugs but typically ease as your body gets used to the medication
Published human pharmacokinetic data for subcutaneous AOD-9604 is not available
Preclinical studies in obese animal models further indicate that AOD 9604 enhances lipolytic activity within adipose tissue, with preferential effects observed in metabolically dysregulated fat cells [2]
PMID: 14636871
US$ 26.78
US$ 26.90
US$ 22.64
US$ 21.87
US$ 28.02
US$ 28.42
US$ 29.36
US$ 26.10
US$ 27.72
US$ 21.61
US$ 20.31
